Atezolizumab vs Buprenorphine

## Atezolizumab vs Buprenorphine: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Buprenorphine**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Buprenorphine — 24-42 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Buprenorphine — C29H41NO4.

**Molecular Weight**: Atezolizumab — N/A; Buprenorphine — 467.6430 g/mol.

**Type**: Atezolizumab — Antibody; Buprenorphine — Small molecule.